These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 14625146)

  • 1. Light-enhanced and fear-potentiated startle: temporal characteristics and effects of alpha-helical corticotropin-releasing hormone.
    de Jongh R; Groenink L; van der Gugten J; Olivier B
    Biol Psychiatry; 2003 Nov; 54(10):1041-8. PubMed ID: 14625146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex.
    Lee Y; Davis M
    J Neurosci; 1997 Aug; 17(16):6434-46. PubMed ID: 9236251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the acoustic startle reflex by infusion of corticotropin-releasing hormone into the nucleus reticularis pontis caudalis.
    Birnbaum SG; Davis M
    Brain Res; 1998 Jan; 782(1-2):318-23. PubMed ID: 9519280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex.
    Bijlsma EY; van Leeuwen ML; Westphal KG; Olivier B; Groenink L
    Neuroscience; 2011 Jan; 173():82-92. PubMed ID: 21093544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fear-potentiated startle and light-enhanced startle models in drug discovery.
    Groenink L; Bijlsma EY; Olivier B
    Curr Protoc Pharmacol; 2008 Jun; Chapter 5():Unit5.48. PubMed ID: 22294228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41).
    Swerdlow NR; Britton KT; Koob GF
    Neuropsychopharmacology; 1989 Dec; 2(4):285-92. PubMed ID: 2610824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiogenic treatments do not increase fear-potentiated startle in mice.
    Risbrough VB; Geyer MA
    Biol Psychiatry; 2005 Jan; 57(1):33-43. PubMed ID: 15607298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favoured genetic background for testing anxiolytics in the fear-potentiated and light-enhanced startle paradigms in the rat.
    Steiner MA; Lecourt H; Rakotoariniaina A; Jenck F
    Behav Brain Res; 2011 Aug; 221(1):34-42. PubMed ID: 21354212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The GABA(B) receptor positive modulator BHF177 attenuated anxiety, but not conditioned fear, in rats.
    Li X; Kaczanowska K; Finn MG; Markou A; Risbrough VB
    Neuropharmacology; 2015 Oct; 97():357-64. PubMed ID: 26002628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and CRF-enhanced startle suggest preferential involvement in sustained vs phasic threat responses.
    Walker D; Yang Y; Ratti E; Corsi M; Trist D; Davis M
    Neuropsychopharmacology; 2009 May; 34(6):1533-42. PubMed ID: 19078950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of sex and neonatal maternal separation on fear-potentiated and light-enhanced startle.
    de Jongh R; Geyer MA; Olivier B; Groenink L
    Behav Brain Res; 2005 Jun; 161(2):190-6. PubMed ID: 15878207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Centrally administered corticotropin-releasing hormone and peripheral injections of strychnine hydrochloride potentiate the acoustic startle response in preweanling rats.
    Weber M; Richardson R
    Behav Neurosci; 2001 Dec; 115(6):1273-82. PubMed ID: 11770058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin-releasing factor: long-lasting facilitation of the acoustic startle reflex.
    Liang KC; Melia KR; Miserendino MJ; Falls WA; Campeau S; Davis M
    J Neurosci; 1992 Jun; 12(6):2303-12. PubMed ID: 1351540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear.
    Walker DL; Davis M
    J Neurosci; 1997 Dec; 17(23):9375-83. PubMed ID: 9364083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central CRF receptor antagonist a-helical CRF9-41 blocks reinstatement of extinguished fear: the role of the bed nucleus of the stria terminalis.
    Waddell J; Bouton ME; Falls WA
    Behav Neurosci; 2008 Oct; 122(5):1061-9. PubMed ID: 18823163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nonextinction procedure for long-term studies of classically conditioned enhancement of acoustic startle in the rat.
    Winston CR; Leavell BJ; Ardayfio PA; Beard C; Commissaris RL
    Physiol Behav; 2001 May; 73(1-2):9-17. PubMed ID: 11399289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the septohippocampal system differentiates anxiety from fear in startle paradigms.
    Veening JG; Böcker KB; Verdouw PM; Olivier B; De Jongh R; Groenink L
    Neuroscience; 2009 Nov; 163(4):1046-60. PubMed ID: 19580851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin-releasing factor in the caudal pontine reticular nucleus mediates the expression of fear-potentiated startle in the rat.
    Fendt M; Koch M; Schnitzler HU
    Eur J Neurosci; 1997 Feb; 9(2):299-305. PubMed ID: 9058050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fear-potentiated startle, but not light-enhanced startle, is enhanced by anxiogenic drugs.
    Bijlsma EY; de Jongh R; Olivier B; Groenink L
    Pharmacol Biochem Behav; 2010 Jul; 96(1):24-31. PubMed ID: 20394767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intracerebral ventricular administration of gastrin-releasing peptide and its receptor antagonist RC-3095 on learned fear responses in the rat.
    Merali Z; Mountney C; Kent P; Anisman H
    Behav Brain Res; 2011 Jan; 216(2):519-24. PubMed ID: 20801162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.